Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
02/2008
02/21/2008WO2008020206A2 Fused thiophene derivatives as mek inhibitors
02/21/2008WO2008019594A1 Agmatine sulfate dihydrate and its medicinal use
02/21/2008WO2008000743A3 Novel 2',3'-methylidene acetyl adenosine prodrugs for use as prodrugs for adenosine receptor agonists
02/21/2008WO2007149451A3 Cycloalkanopyrrolocarbazole derivatives and the use thereof as parp, vegfr2 and mlk3 inhibitors
02/21/2008US20080045709 3-(4-amidopyrrol-2-ylmethylidene)-2-indolinone derivatives as protein kinase inhibitors
02/21/2008US20080045594 Use of at Least One Conjugated Triene-Containing Fatty Acid for Preparing a Medicine for Treating Inflammation
02/21/2008US20080045591 (E)-7,7-Dimethyl-1-(4-hydroxy-3-methoxyphenyl)-oct-1-ene-3,5-dione; (E)-1-(4-Hydroxy-3-methoxyphenyl)-6-methyl-hept-1-ene-3,5-dione; prophylaxis of hypersensitivity, smooth muscle disorders, spasmodic conditions, allergic conditions, inflammatory conditions and/or pain
02/21/2008US20080045586 Oxydecahydronaphthalene modulators of hm74
02/21/2008US20080045582 ENA-78 Gene Polymorphisms and Protein Concentrations as Diagnostic and Prognostic Tools
02/21/2008US20080045580 Novel Isoxazole Compounds Having Ppar Agonist Activity
02/21/2008US20080045571 Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
02/21/2008US20080045549 Adenosine a2b receptor antagonists
02/21/2008US20080045531 Anti-inflammatory medicaments
02/21/2008US20080045529 Use Of Thienopyrimidines
02/21/2008US20080045522 Omega-aminoalkylamides of r-2-aryl-propionic acids as inhibitors of the chemotaxis of polymorphonucleate and mononucleate cells
02/21/2008US20080045513 Combination faah inhibitor and analgesic, anti-inflammatory or anti-pyretic agent
02/21/2008US20080045503 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
02/21/2008US20080045489 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands
02/21/2008US20080045455 RAGE fusion proteins, formulations, and methods of use thereof
02/21/2008US20080045443 Compositions for Inhibiting plexin-A1-DAP12 interactions and Methods of Treating Inflammatory, Autoimmune or Bone Resorption Diseases Using the Same
02/21/2008US20080044502 Use of an aqueous or hydroalcoholic extract of bauhinia for the preparation of a composition
02/21/2008US20080044487 Anti-inflammatory properties of marine lipid compositions
02/21/2008US20080044476 Mixture of corticosteroid and sodium hyaluronate in aqueous carrier
02/21/2008US20080044472 Photoresponsive Hydrogels
02/21/2008US20080044465 Therapy for cellular accumulation in chronic inflammatory diseases
02/21/2008US20080044463 Bradykinin B2 Receptor Antagonist Peptide From Amphibian Skin
02/21/2008US20080044444 Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
02/21/2008US20080044423 Compounds
02/21/2008US20080044409 Inflammatory mediator antagonists
02/21/2008US20080044402 Use of fermented wheat-germ in the feeding and veterinary practice
02/21/2008US20080044385 Novel Modified Galectin 8 Proteins and Use Thereof
02/21/2008US20080044354 Compounds Containing a N-Heteroaryl Moiety Linked to Fused Ring Moieties for the Inhibition of Nad(P)H Oxidases and Platelet Activation
02/21/2008US20080042818 Trailer tire alert system
02/21/2008US20080041367 NMDA Receptor Antagonist Formulation With Reduced Neurotoxicity
02/21/2008DE102006039003A1 Neue Verbindungen New connections
02/21/2008DE102006038252A1 Zubereitung mit marinem Kollagen zur Proteinasehemmung Preparation with marine collagen to Proteinasehemmung
02/21/2008CA2660836A1 Triazolotriazines as kinase inhibitors
02/21/2008CA2650206A1 Novel crystal of 5-aminolevulinic acid phosphate and process for producing the same
02/20/2008EP1889839A1 Bicyclic compound, production and use as HIV inhibitors
02/20/2008EP1889639A2 Methods and compositions containing succinimide or maleimide derivatives of antineoplastic agents, for producing long lasting antineoplastic agents
02/20/2008EP1889621A1 Multiparticulates
02/20/2008EP1888640A2 Improved nanobodies against tumor necrosis factor-alpha
02/20/2008EP1888618A2 Analogs of glycyl-prolyl-glutamate
02/20/2008EP1888596A1 Substituted spiro compounds and their use for producing pain-relief medicaments
02/20/2008EP1888595A2 Spiro-oxindole compounds and their uses as therapeutic agents
02/20/2008EP1888592A1 Spiroheterocyclic compounds and their uses as therapeutic agents
02/20/2008EP1888591A2 Derivatives of 6,7-dihydro-5h-imidazo[1,2-a]imidazole-3-sulfonic acid
02/20/2008EP1888586A2 2,3-substituted fused bicyclic pyrimidin-4(3h)-ones which modulate the function of the vanilloid-1 receptor (vr1)
02/20/2008EP1888578A2 Imidazoquinolines as lipid kinase inhibitors
02/20/2008EP1888575A2 Compounds for modulating trpv3 function
02/20/2008EP1888555A2 Substituted benzo-condensed cyclohexanone derivatives and the use thereof for medicament production
02/20/2008EP1888547A1 Indane derivatives as modulators of ion channels
02/20/2008EP1888541A1 Benzo(d)isoxazol-3-yl-amine compounds and their use as vanilloid receptor ligands
02/20/2008EP1888528A2 Phosphodiesterase 4 inhibitors
02/20/2008EP1888514A1 Salts of substituted allophanates and their use in drugs
02/20/2008EP1888505A1 Organic compounds
02/20/2008EP1888122A2 A method for preparing a stable immunogenic product comprising antigenic heterocomplexes of tnf alpha and a carrier protein
02/20/2008EP1888091A2 Use of the irritating principal oleocanthal in olive oil, as well as structurally and functionally similar compounds
02/20/2008EP1888033A2 Method and composition for treating inflammatory disorders
02/20/2008EP1888027A1 Medicated product for local use based on natural materials
02/20/2008EP1888025A2 Medicament carrier composition and method of forming a film therefrom
02/20/2008EP1722771A4 Compositions and methods for preventing or treating an inflammatory response
02/20/2008EP1427392B1 New self emulsifying drug delivery system
02/20/2008EP1406667B1 Methods for increasing in vivo efficacy of oligonucleotides and inhibiting inflammation in mammals
02/20/2008EP1383747B1 Fused pyrimidines as antagonists of the corticotropin releasing factor (crf)
02/20/2008EP1225915B1 Use of anti-il-2 polyclonal antibodies for the treatment of insulin-dependent diabetes mellitus and lupus erythematosus
02/20/2008EP0951281B9 2-CYCLOPENTEN-1-ONE AND ITS DERIVATIVES AS INHIBITORS OF THE NF-kappa B FACTOR
02/20/2008CN201022856Y Medicine plaster for treating bone pains of numbness
02/20/2008CN201022854Y Double rings medicine plaster
02/20/2008CN101128470A New compounds
02/20/2008CN101128453A 2-sulfinyl- and 2-sulfonyl-substituted imidazole derivatives and their use as cytokine inhibitors
02/20/2008CN101128452A Novel benzoimidazole derivatives and a pharmaceutical composition comprising the same
02/20/2008CN101128451A Derivatives of n-[(4,5-diphenyl-2-thienyl)methyl]amine, their preparations and therapeutic application
02/20/2008CN101128430A Pyridine compounds for the treatment of prostaglandin mediated diseases
02/20/2008CN101128427A Heterocyclic compounds as ccr2b antagonists
02/20/2008CN101128193A Anti-radical agents
02/20/2008CN101125850A Andrographolide derivatives and application of the same in pharmacy
02/20/2008CN101125206A Diolpolymer-interleukin-1 receptor antagonists conjugate and preparation method and application
02/20/2008CN101125190A Powdered medicine active carbon mixture and preparation method thereof
02/20/2008CN101125180A Traditional Chinese medicine for curing rheumatism
02/20/2008CN101125166A External-applied traditional Chinese medicine for treating rheumatism
02/20/2008CN101125146A Medicine target for preventing and treating cardiovascular and cerebrovascular diseases associated with inflammation and its inhibitor
02/20/2008CN101125145A Local using prostaglandin micro emulsion and its preparation method
02/20/2008CN101125138A Inhibitors against the production and release of inflammatory cytokines
02/20/2008CN101125137A Pharmaceutical salts
02/20/2008CN101125136A Application of alpinia officinarum hance diarylheptanes compound in pain-alleviating and anti-inflammatory and its extracting method
02/20/2008CN101125135A Artemether cataplasma and its application
02/20/2008CN101125129A Acemetacin sustained-release preparation and preparation method
02/20/2008CN100369919C Tricyclic protein kinase inhibitors
02/20/2008CN100369917C Himbacine analogues as thrombin receptor antagonists
02/20/2008CN100369903C Five-membered-ring compound
02/20/2008CN100369898C Nicotinamide derivates useful as p38 inhibitors
02/20/2008CN100369894C Nitric oxide synthase inhibitor phosphate salt
02/20/2008CN100369891C HIF hydroxylase inhibitors
02/20/2008CN100369888C N-alkanoylphenylalanine derivatives
02/20/2008CN100369607C Oral liquor slow releasing preparation containing codeine and chlorophenamine and its preparing method
02/19/2008US7332517 1-(1H-indol-3-ylmethyl)-3-(4-nitrophenyl)-5-[2-(4-phenyl-1H-imidazol-2-yl)ethyl]-2thioxo-4imidazolidinone; somastatin receptor affinity; acromegaly, hypophyseal adenomas, endocrine gastroenteropancreatic tumors, as carcinoid syndrome and gastrointestinal bleeding
02/19/2008US7332511 Vanilloid receptor ligands and their use in treatments
02/19/2008US7332507 Cholinergic ligands at the nicotinic acetylcholine receptors and modulators of the monoamine receptors and transporters; treating pain, neurodegeneration, inflammation, and drug or alcohol withdrawal symptoms; 3-benzimidazole, indole or triazole substituted
02/19/2008US7332503 Aporphine esters and their use in therapy
1 ... 493 494 495 496 497 498 499 500 501 502 503 504 505 506 507 508 509 510 511 512 513 ... 1272